Stocktoria
Ceribell, Inc. CBLL
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2024-10-11
Ceribell, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Gross margin | 87.9% | 86.7% | 84.4% |
| Operating margin | -65.6% | -60.7% | -66.4% |
| Net margin | -60.0% | -61.8% | -65.1% |
| FCF margin | -46.7% | -55.6% | -66.6% |
| Return on assets | -27.3% | -17.9% | -50.0% |
| Return on equity | -34.4% | -21.2% | 26.2% |
| Current ratio | 9.73 | 16.73 | 2.41 |
| Revenue growth | 36.1% | 44.7% | — |
Source: SEC EDGAR filings · CIK 0001861107 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.